Toprol-xl and Lucentis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Toprol-xl (metoprolol succinate) and Lucentis (ranibizumab). Common drug interactions include lip pain among females and visual acuity reduced among males.

The phase IV clinical study analyzes what interactions people have when they take Toprol-xl and Lucentis. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Toprol-xl?

Toprol-xl has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 40,636 Toprol-xl users. Check the latest studies of Toprol-xl.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

On Jul, 12, 2026

39 people who take Toprol-xl and Lucentis together, and have interactions are studied.

Toprol-xl and Lucentis drug interactions.

What are the common drug interactions of Toprol-Xl and Lucentis, by gender? *:

female:

Lip pain
Lip swelling
Rash
Upper respiratory tract infection
Burning sensation
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Contusion (a type of hematoma of tissue in which capillaries)
Eye haemorrhage (bleeding in the eye)
Eye pain
Headache (pain in head)

male:

Visual acuity reduced (reduced clearness of vision)
Intraocular pressure increased
Pneumonia
Visual impairment
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)

What are the common drug interactions of Toprol-Xl and Lucentis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Intraocular pressure increased
Lip pain
Headache (pain in head)
Upper respiratory tract infection
Visual impairment
Vitreous floaters (spots before the eyes)
White blood cell count increased
Bone pain
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Dizziness

What are the existing conditions these people have? *

Stress And Anxiety: 2 people, 5.13%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 2 people, 5.13%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.13%
High Blood Cholesterol: 2 people, 5.13%
Diabetes: 2 people, 5.13%
Cardiac Disorder: 2 people, 5.13%
Bone Disorder: 2 people, 5.13%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Toprol-xl and Lucentis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously